Announcements and Circulars
-
- 28 Nov 2023
- Announcements and Notices - [List of Directors and their Role and Function] LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
-
- 28 Nov 2023
- Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities] (1) RESIGNATION OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR (2) APPOINTMENT OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR
-
- 03 Nov 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
-
- 04 Oct 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
-
- 04 Sep 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
-
- 25 Aug 2023
- Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
-
- 20 Aug 2023
- Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT BUSINESS COOPERATION AGREEMENT WITH JIANGSU SIMCERE ZAIMING IN RELATION TO CMAB009 IN CHINA
-
- 14 Aug 2023
- Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
-
- 02 Aug 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
-
- 04 Jul 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
-
- 16 Jun 2023
- Announcements and Notices - [Results of AGM] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 16 JUNE 2023
-
- 06 Jun 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
-
- 23 May 2023
- Announcements and Notices - [Inside Information] INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ON THE NEW DRUG APPLICATION (NDA) OF OUR CORE PRODUCT, CMAB007 (OMALIZUMAB ALFA FOR INJECTION)
-
- 05 May 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
-
- 20 Apr 2023
- Proxy Forms FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 16, 2023
-
- 20 Apr 2023
- Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period] NOTICE OF ANNUAL GENERAL MEETING
-
- 20 Apr 2023
- Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval] PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
-
- 13 Apr 2023
- Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT EXCLUSIVE PROMOTION AGREEMENT WITH JEMINCARE IN RELATION TO CMAB007 IN CHINA
-
- 04 Apr 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
-
- 24 Mar 2023
- Announcements and Notices - [Terms of Reference of the Remuneration Committee] Terms of reference of the Remuneration Committee
-
- 24 Mar 2023
- Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
-
- 15 Mar 2023
- Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
-
- 14 Mar 2023
- Announcements and Notices - [Inside Information] INSIDE INFORMATION ANNOUNCEMENT ACCEPTANCE OF THE NEW DRUG APPLICATION (NDA) OF OUR CORE PRODUCT CMAB009 BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
-
- 03 Mar 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
-
- 06 Feb 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
-
- 04 Jan 2023
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022